UPDATE 1-U.S. FDA approves Puma Biotech's breast cancer treatment
July 17, 2017 at 17:52 PM EDT
July 17 (Reuters) - The U.S. Food and Drug Administration (FDA) on Monday approved Puma Biotechnology Inc's experimental breast cancer drug that lowers the risk of the disease returning after initial treatment.
